Wild-type TP53 ovarian cancer cell lines were treated for 24 hours with 1x and 2x their respective Nutlin-3/RG7388 GI50 concentrations as a single agent and in combination with cisplatin (Figure 4C & 5C). Here, TP53 is linked to ovarian carcinoma.